Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
35.61
-0.23 (-0.64%)
Apr 30, 2026, 4:00 PM EDT - Market closed
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $2.55 billion as of May 1, 2026. Its market cap has increased by 85.48% in one year.
Market Cap
2.55B
Enterprise Value
1.92B
1-Year Change
85.48%
Ranking
Category
Stock Price
$35.61
Market Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $2.55B, an increase of 1,033.62%. That is a compound annual growth rate of 63.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 2.55B | -28.96% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | 225.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 2.83B |
| Kodiak Sciences | 2.82B |
| Soleno Therapeutics | 2.73B |
| Immunome | 2.68B |
| Tarsus Pharmaceuticals | 2.64B |
| Celldex Therapeutics | 2.61B |
| Enliven Therapeutics | 2.57B |
| Disc Medicine | 2.57B |